Onconetix Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Net Income	-37.41	-13.52	-4.04	-2.16	-1.1
Depreciation & Amortization	0.04	0.01	0	0	0
Share-Based Compensation	0.33	1.97	0.13	0.33	0
Other Operating Activities	23.45	2.76	1.24	-0.47	-0.01
Operating Cash Flow	-13.58	-8.68	-2.04	-1.73	-0.83
Capital Expenditures	-0.06	-0.01	-0	-0.01	-0
Acquisitions	-8.59	-0.02	0	0	0
Investing Cash Flow	-8.65	-0.03	-0	-0.01	-0
Share Issuance / Repurchase	-0.06	33.38	0	0	0
Debt Issued / Paid	-1	0	0	0	-0.05
Other Financing Activities	2.09	-0.84	-0.33	-	6.93
Financing Cash Flow	1.04	32.53	-0.33	0	6.88
Exchange Rate Effect	-0	0	0	0	0
Net Cash Flow	-21.2	23.82	-2.38	-1.74	6.05
Free Cash Flow	-13.64	-8.68	-2.05	-1.74	-0.83
Free Cash Flow Margin	-23323.46%	-	-	-	-
Free Cash Flow Per Share	-0.80	-0.71	-0.64	-0.54	-0.26

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).